Cytokinetics’ Post
More Relevant Posts
-
We are incredibly proud to announce the release of Resilience in the Fight Against ALS, the story of our decade-long journey to discover and develop a potential medicine for ALS. We endured both challenges and triumphs in our journey in #ALS, and our goal to bring forward a new medicine for people living with ALS was not realized. However, while some may deem that a defeat, we see it as anything but that. In fact, we are grateful for the opportunities our dedication to the fight against ALS has afforded us. The book recounts our company’s lessons and learnings and serves to pass the baton to those developing potential new medicines for ALS to help light the path to future success. It also highlights many key individuals, including people living with ALS, caregivers, advocates and clinicians who inspired us along the way. Resilience in the Fight Against ALS is now available as a free eBook and downloadable PDF. Learn more here. https://bit.ly/4bVKy04
To view or add a comment, sign in
-
-
Cytokinetics is dedicated to reducing our waste. Did you know that it’s Plastic-Free July? This global movement from the Plastic Free July Foundation challenges us to refuse single-use plastics. Let’s create a more #sustainable world through our actions big and small. Find tips here: https://bit.ly/3yfli6X #plasticfreejuly
To view or add a comment, sign in
-
-
The ALS Therapy Development Institute (ALS TDI) is a recipient of our 2024 Communications Grant program. With the grant, they will launch the ALS Trial Navigator. This unique online #platform will guide #patients as they learn more about finding and participating in clinical trials for experimental #ALS #treatments. https://bit.ly/4cK9oBd
To view or add a comment, sign in
-
-
We are happy to share that Cytokinetics is one of Great Place To Work US & Fortune's top 100 #BestWorkplaces for #Millennials! A huge thank you to everyone who makes Cytokinetics an exceptional place to work. https://bit.ly/3Lxc8G1
To view or add a comment, sign in
-
We are pleased to announce seven upcoming presentations, including four late-breaking clinical trial presentations related to our investigational cardiac myosin inhibitor at the European Society of Cardiology Congress 2024 in #London Aug. 30 – Sept. 2, 2024. #ESCCongress #HCM https://bit.ly/4cLL1my
To view or add a comment, sign in
-
There’s never been a better time to join our team if you are looking for a career to empower yourself, empower your community and empower patients. At Cytokinetics, you’ll work on a team of talented individuals who share a common goal of developing potential medicines for people with diseases of impaired muscle function. If you are interested in a career at a biopharmaceutical company where you will feel empowered in the work you do, check out our open positions. https://bit.ly/4bKRM6I #EmpoweredAtCytokinetics #hiring
To view or add a comment, sign in
-
-
July is Disability Pride Month! Let's elevate the contributions and experiences of people with disabilities, fight stigma, and advocate for a more inclusive world. #DisabilityPride
To view or add a comment, sign in
-
-
Help us welcome our 2024 summer interns! This year we have 23 interns working with mentors across the company to gain valuable #biopharma experience on teams ranging from HR to Discovery Biology. Our internship program is one of our many commitments to pay it forward by nurturing and supporting young biotech professionals. Learn more: https://bit.ly/4biWtEE #internship2024 #interns
To view or add a comment, sign in
-
-
At Cytokinetics, we're committed to creating an environment where all of our #LGBTQIA+ colleagues feel empowered to bring their authentic selves to work. We stand strong in our commitment to championing diversity, fostering inclusion, and advocating for equity and respect, not just this month, but every day. #PrideMonth
To view or add a comment, sign in
-